Загрузка...
Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation
Ceftolozane-tazobactam is a cephalosporin-β-lactamase inhibitor combination that exhibits potent in vitro activity against Pseudomonas aeruginosa, including strains that are resistant to other β-lactams. The emergence of ceftolozane-tazobactam resistance among clinical isolates of P. aeruginosa has...
Сохранить в:
| Опубликовано в: : | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700322/ https://ncbi.nlm.nih.gov/pubmed/28947473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01183-17 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|